147 related articles for article (PubMed ID: 17973210)
1. Age-specific characteristics of the basal insulin-rate for pediatric patients on CSII.
Klinkert C; Bachran R; Heidtmann B; Grabert M; Holl RW;
Exp Clin Endocrinol Diabetes; 2008 Feb; 116(2):118-22. PubMed ID: 17973210
[TBL] [Abstract][Full Text] [Related]
2. Choice of basal insulin therapy is associated with weight and height development in type 1 diabetes: A multicenter analysis from the German/Austrian DPV registry in 10 338 children and adolescents.
Vollbach H; Auzanneau M; Reinehr T; Wiegand S; Schwab KO; Oeverink R; Froehlich-Reiterer E; Woelfle J; De Beaufort C; Kapellen T; Gohlke B; Holl RW
J Diabetes; 2021 Nov; 13(11):930-939. PubMed ID: 34184423
[TBL] [Abstract][Full Text] [Related]
3. Basal rates and circadian profiles in continuous subcutaneous insulin infusion (CSII) differ for preschool children, prepubertal children, adolescents and young adults.
Bachran R; Beyer P; Klinkert C; Heidtmann B; Rosenbauer J; Holl RW; ; ;
Pediatr Diabetes; 2012 Feb; 13(1):1-5. PubMed ID: 21545675
[TBL] [Abstract][Full Text] [Related]
4. Continuous Subcutaneous Insulin Infusion in Neonates and Infants Below 1 Year: Analysis of Initial Bolus and Basal Rate Based on the Experiences from the German Working Group for Pediatric Pump Treatment.
Kapellen TM; Heidtmann B; Lilienthal E; Rami-Merhar B; Engler-Schmidt C; Holl RW
Diabetes Technol Ther; 2015 Dec; 17(12):872-9. PubMed ID: 26509360
[TBL] [Abstract][Full Text] [Related]
5. Beneficial effects of continuous subcutaneous insulin infusion and flexible multiple daily insulin regimen using insulin glargine in type 1 diabetes.
Alemzadeh R; Ellis JN; Holzum MK; Parton EA; Wyatt DT
Pediatrics; 2004 Jul; 114(1):e91-5. PubMed ID: 15231979
[TBL] [Abstract][Full Text] [Related]
6. Age-dependent basal insulin patterns in children with type 1 diabetes treated with continuous subcutaneous insulin infusion.
Szypowska A; Lipka M; Błazik M; Golicka D; Groele L; Pańkowska E
Acta Paediatr; 2009 Mar; 98(3):523-6. PubMed ID: 19046348
[TBL] [Abstract][Full Text] [Related]
7. Continuous subcutaneous insulin infusion vs modern multiple injection regimens in type 1 diabetes: an updated meta-analysis of randomized clinical trials.
Pala L; Dicembrini I; Mannucci E
Acta Diabetol; 2019 Sep; 56(9):973-980. PubMed ID: 30945047
[TBL] [Abstract][Full Text] [Related]
8. Difference in insulin usage patterns with pubertal development in children with type 1 diabetes during transition from multiple daily injections to continuous subcutaneous insulin infusion (CSII) and through the CSII treatment.
Shashaj B; Sulli N
Diabetes Technol Ther; 2009 Dec; 11(12):767-74. PubMed ID: 20001677
[TBL] [Abstract][Full Text] [Related]
9. Proportion of Basal to Total Insulin Dose Is Associated with Metabolic Control, Body Mass Index, and Treatment Modality in Children with Type 1 Diabetes-A Cross-Sectional Study with Data from the International SWEET Registry.
Rasmussen VF; Vestergaard ET; Schwandt A; Beltrand J; Rami-Merhar B; O'Riordan SMP; Jarosz-Chobot P; Castro-Correia C; Gevers EF; Birkebæk NH
J Pediatr; 2019 Dec; 215():216-222.e1. PubMed ID: 31345576
[TBL] [Abstract][Full Text] [Related]
10. Basal insulin requirements on continuous subcutaneous insulin infusion during the first 12 months after diagnosis of type 1 diabetes mellitus.
Ramchandani N; Ellis MK; Jain S; Bhandari S; Anhalt H; Maclaren NK; Ten S
J Diabetes Sci Technol; 2010 May; 4(3):610-4. PubMed ID: 20513327
[TBL] [Abstract][Full Text] [Related]
11. Basal insulin supplementation in Type 1 diabetic children: a long-term comparative observational study between continuous subcutaneous insulin infusion and glargine insulin.
Schiaffini R; Patera PI; Bizzarri C; Ciampalini P; Cappa M
J Endocrinol Invest; 2007; 30(7):572-7. PubMed ID: 17848840
[TBL] [Abstract][Full Text] [Related]
12. Glargine basal-bolus insulin regimen versus insulin pump therapy: comparison of glycemic control.
Starkman H; Frydman E; Bustami R
J Pediatr Endocrinol Metab; 2011; 24(5-6):369-71. PubMed ID: 21823538
[TBL] [Abstract][Full Text] [Related]
13. Memory of insulin pumps and their record as a source of information about insulin therapy in children and adolescents with type 1 diabetes.
Pańkowska E; Skórka A; Szypowska A; Lipka M
Diabetes Technol Ther; 2005 Apr; 7(2):308-14. PubMed ID: 15857233
[TBL] [Abstract][Full Text] [Related]
14. Continuous subcutaneous insulin infusion and multiple dose of insulin regimen display similar patterns of blood glucose excursions in pediatric type 1 diabetes.
Alemzadeh R; Palma-Sisto P; Parton EA; Holzum MK
Diabetes Technol Ther; 2005 Aug; 7(4):587-96. PubMed ID: 16120030
[TBL] [Abstract][Full Text] [Related]
15. Initial Basal and Bolus Rates and Basal Rate Variability During Pump Treatment in Children and Adolescents.
Demir G; Atik Altınok Y; Özen S; Darcan Ş; Gökşen D
J Clin Res Pediatr Endocrinol; 2021 Jun; 13(2):198-203. PubMed ID: 33374094
[TBL] [Abstract][Full Text] [Related]
16. Feasibility of continuous subcutaneous insulin infusion and daily supplemental insulin glargine injection in children with type 1 diabetes.
Alemzadeh R; Parton EA; Holzum MK
Diabetes Technol Ther; 2009 Aug; 11(8):481-6. PubMed ID: 19698060
[TBL] [Abstract][Full Text] [Related]
17. Classification of distinct baseline insulin infusion patterns in children and adolescents with type 1 diabetes on continuous subcutaneous insulin infusion therapy.
Holterhus PM; Odendahl R; Oesingmann S; Lepler R; Wagner V; Hiort O; Holl R; ;
Diabetes Care; 2007 Mar; 30(3):568-73. PubMed ID: 17327322
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of insulin pump therapy: mealtime delivery is the key factor.
Crawford LM; Sinha RN; Odell RM; Comi RJ
Endocr Pract; 2000; 6(3):239-43. PubMed ID: 11421538
[TBL] [Abstract][Full Text] [Related]
19. An observational study comparing continuous subcutaneous insulin infusion (CSII) and insulin glargine in children with type 1 diabetes.
Schiaffini R; Ciampalini P; Spera S; Cappa M; Crinó A
Diabetes Metab Res Rev; 2005; 21(4):347-52. PubMed ID: 15619291
[TBL] [Abstract][Full Text] [Related]
20. A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine.
Doyle EA; Weinzimer SA; Steffen AT; Ahern JA; Vincent M; Tamborlane WV
Diabetes Care; 2004 Jul; 27(7):1554-8. PubMed ID: 15220227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
